BIT

6.67%

3.2¢ biotron limited

Lord of the fly’s is slagging BIT daily to suit it’s own agenda,...

First 96 Last

Share
Profile

Follow
Scooterdog

5,916 Posts.

237

16/07/24

12:49

Post #: 74773548
Share

Originally posted by NZ Trader: ↑

Always in the vacuum of News/ Updates there are questions surrounding "what are management up to , what are they achieving"?

SH need to focus on the Game and not the players ... just because there is no market action doesn't mean that Management are inactive..
Had a little more time to reflect on the last presentation , The CEO obviously has ignored previous correspondence from certain SH? in this game you have to "Craft" your questions so a CEO has the ability to answer...
The recent message is " We have signed hundreds of NDA's" "we can not disclose who we are in Discussions with"
Plus the big one I believe the market missed " We have Met our Primary Endpoints"

BIT225-011 Phase 2 HIV Exploratory Efficacy Trial Meets Primary Objectives

 Preliminary analyses indicate that the primary objectives of the trial have been met.
 The results extend the previously reported effects of BIT225 to an HIV-infected population that has
not achieved full immune reconstitution despite long-term suppressive antiretroviral treatment.

The Directors of Biotron Limited (the Company) are pleased to advise that preliminary analyses of data from
the BIT225-011 Phase 2 clinical trial of the Company’s lead antiviral drug BIT225 indicate that the primary
objectives of the trial have been met.

This longitudinal, open-label Phase 2 trial was designed to characterise the effect of BIT225 (200 mg, once
daily) added to ongoing, suppressive standard of care antiretroviral therapy (cART) for twelve weeks in twenty
HIV-1 infected, treatment-experienced participants who had achieved only partial immune reconstitution. Trial
details are set out in the attached Addendum.
The primary objectives of the trial were to evaluate the safety and tolerability of BIT225 in this patient
population, as well as to determine the impact of the addition of BIT225 to cART on immune activation,
inflammation and viral markers.

Understand many are jaded with the Company and management but do keep in mind "All those that hold are Invested n the Same Company"
Varying Views and Opinions are always welcomed on the Forums but just openly abusing and slagging other Posters does nothing to assist with welcoming potential new investors.. NZT

Expand

Lord of the fly’s is slagging BIT daily to suit it’s own agenda, very different story to what goes on with the stock it owns.

BIT Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Nine's staff strike as Paris Olympic coverage begins

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

ASX Market Open: ASX200 to rise for Friday session | July 26

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

There are more pages in this discussion • 29 more messages in this thread...

First 96 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 3.2¢		Change 0.002(6.67%)		Mkt cap ! $28.87M

Open	High	Low	Value	Volume
3.1¢	3.3¢	3.1¢	$13.79K	424.2K

Buyers (Bids)

No.	Vol.	Price($)
1	329429	3.2¢

Sellers (Offers)

Price($)	Vol.	No.
3.4¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	329429	0.032
3	81516	0.031
8	342305	0.030
3	1008888	0.029
4	468000	0.028

Price($)	Vol.	No.
0.034	100000	1
0.035	347547	4
0.037	537816	2
0.038	162500	1
0.039	317353	2

Last trade - 15.51pm 26/07/2024 (20 minute delay)

BIT (ASX) Chart

Lord of the fly’s is slagging BIT daily to suit it’s own agenda,...

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Nine's staff strike as Paris Olympic coverage begins

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

ASX Market Open: ASX200 to rise for Friday session | July 26

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Lord of the fly’s is slagging BIT daily to suit it’s own agenda,...

Top Stories

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Nine's staff strike as Paris Olympic coverage begins

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

ASX Market Open: ASX200 to rise for Friday session | July 26

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News